Noted cancer researcher joins YSU

Severine Van slambrouck, a noted cancer researcher who has secured more than $2.5 million in research funding in her 15-year academic career, is the new director of Research, Compliance and Initiatives at Youngstown State University.

"We are very fortunate to have someone with Severine's vast experience and expertise to help advance research initiatives here at YSU and across the Mahoning Valley," said Greg Dillon, interim associate vice president of Research at YSU.

Van slambrouck, who holds a PhD in Chemistry from New Mexico Institute of Mining and Technology, will provide campus-wide leadership in the development of externally funded grants and contracts; devise, implement and update policies and procedures to promote grant proposal development; and oversee management and compliance for all grants and contracts awarded to YSU.

Before coming to YSU, Van slambrouck was an assistant professor of Biochemistry at South Dakota State University, assistant professor of Chemistry at St. Thomas University in Florida, research associate professor at New Mexico Tech, and she obtained a fellowship from the Union for International Cancer Control to spend several months visiting the Structural and Functional Glycobiology Unit of the University of Sciences and Technology in Lille, France. She started her research training in the Laboratory of Experimental Cancer Research at the Medical School of Ghent University in 1999.

Van slambrouck, who also earned bachelor’s and master’s degrees in Pharmaceutical Sciences from Ghent University in Belgium, has published nearly 30 peer-reviewed research papers and has served on grant review panels of the National Science Foundation and other international research foundations.

Among her many honors is the Research Award for Outstanding Achievement at the 21st World Congress on Advances in Oncology and 19th International Symposium on Molecular Medicine in Athens, Greece; the Leo and Elaine Spinar Teaching Award, recognizing Undergraduate Teaching Excellence at South Dakota State University; and the Research Award for Outstanding Achievement at the 13th World Congress on Advances in Oncology and 11th International Symposium on Molecular Medicine in Crete, Greece.